AU2003202032A1 - Determining chemotherapeutic effectiveness - Google Patents

Determining chemotherapeutic effectiveness

Info

Publication number
AU2003202032A1
AU2003202032A1 AU2003202032A AU2003202032A AU2003202032A1 AU 2003202032 A1 AU2003202032 A1 AU 2003202032A1 AU 2003202032 A AU2003202032 A AU 2003202032A AU 2003202032 A AU2003202032 A AU 2003202032A AU 2003202032 A1 AU2003202032 A1 AU 2003202032A1
Authority
AU
Australia
Prior art keywords
determining
chemotherapeutic effectiveness
effectiveness
determining chemotherapeutic
chemotherapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003202032A
Inventor
Gareth Joseph Griffiths
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Victoria University of Manchester
Original Assignee
Victoria University of Manchester
University of Manchester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Victoria University of Manchester, University of Manchester filed Critical Victoria University of Manchester
Publication of AU2003202032A1 publication Critical patent/AU2003202032A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00—Detection of programmed cell death, i.e. apoptosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003202032A 2002-01-17 2003-01-17 Determining chemotherapeutic effectiveness Abandoned AU2003202032A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0200971A GB0200971D0 (en) 2002-01-17 2002-01-17 Determining chemotherapeutic effectiveness
GB0200971.0 2002-01-17
PCT/GB2003/000162 WO2003062828A2 (en) 2002-01-17 2003-01-17 Determining chemotherapeutic effectiveness

Publications (1)

Publication Number Publication Date
AU2003202032A1 true AU2003202032A1 (en) 2003-09-02

Family

ID=9929196

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003202032A Abandoned AU2003202032A1 (en) 2002-01-17 2003-01-17 Determining chemotherapeutic effectiveness

Country Status (3)

Country Link
AU (1) AU2003202032A1 (en)
GB (1) GB0200971D0 (en)
WO (1) WO2003062828A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014202830A1 (en) * 2014-05-23 2015-12-10 The Walter And Eliza Hall Institute Of Medical Research Bak binding proteins

Also Published As

Publication number Publication date
GB0200971D0 (en) 2002-03-06
WO2003062828A2 (en) 2003-07-31
WO2003062828A3 (en) 2004-01-08

Similar Documents

Publication Publication Date Title
AU2003287136A1 (en) Novel compounds having selective inhibiting effect at gsk3
AU2002335152A1 (en) Robot-phone
AU2002952696A0 (en) Status determination
AU2003200567A1 (en) Level
AU2003270351A1 (en) Anesthetic-state determining
AU2002367810A1 (en) Bis-transition-metal-chelate-probes
AU2003202032A1 (en) Determining chemotherapeutic effectiveness
AU2002318053A1 (en) Suplier
AU2002368348A1 (en) Electrosomatogram
AU2002341221A1 (en) Honey-brandy
AU2002348964A1 (en) Snowbike
AU2003205816A1 (en) Identifying chemotherapeutic compounds
AU2002344387A1 (en) Multifunction-pillow
GB0215173D0 (en) Determining gene function
AU2002100957A4 (en) Sluggit
AU2002100508A4 (en) Photocard
AU2002100541A4 (en) Backmate
AU2002100602A4 (en) Bonsystem
AU2002100655A4 (en) Armamulch
AU2002100739A4 (en) Neuramax
AU2002100747A4 (en) Powersell
AU2002100280A4 (en) Proshoe
AU2002100026A4 (en) Disc400
AU2002100031A4 (en) earliPay
AU2002100498A4 (en) Linline

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase